NASDAQ: GDTCCytomed Therapeutics Ltd Stock Ownership - Who owns Cytomed Therapeutics?
Insider buying vs selling
Have Cytomed Therapeutics Ltd insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Chee Kong Choo | Director | 2026-07-20 | 100,000 | $1.50 | $150.00kBuy |
| Chee Kong Choo | Director | 2026-07-20 | 100,000 | $1.50 | $150.00kBuy |
| Chee Kong Choo | Director | 2026-07-14 | 100,000 | $1.50 | $150.00kBuy |
| Chee Kong Choo | Director | 2026-07-14 | 100,000 | $1.50 | $150.00kBuy |
| Chee Kong Choo | Director | 2026-05-13 | 112,000 | $1.15 | $128.80kBuy |
GDTC insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when GDTC insiders and whales buy or sell their stock.
GDTC Shareholders
What type of owners hold Cytomed Therapeutics Ltd stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Glorious Finance Ltd | 38.99% | 4,653,604 | $4.28M | Insider |
| Chee Kong Choo | 27.74% | 3,310,261 | $3.04M | Insider |
| Shu Wang | 7.41% | 883,858 | $812.27k | Insider |
| Jieming Zeng | 4.94% | 589,239 | $541.51k | Insider |
| Lucas Tien Wee Luk | 0.78% | 92,563 | $85.07k | Insider |
| Yvonne Goh | 0.22% | 25,781 | $23.69k | Insider |
| Yoong Ying Tan | 0.22% | 25,781 | $23.69k | Insider |
| Keng Kiat Toh | 0.03% | 4,000 | $3.68k | Insider |
| Chak Hua Yew | 0.02% | 2,469 | $2.27k | Insider |
| Axiom1 | 0.00% | 7 | $6.43 | Institution |
GDTC vs Biotech Stocks
Cytomed Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.